Biogen takes second royalties victory in blow for Forward Pharma
Danish biotech company Forward Pharma has once again lost out to US-based firm Biogen, after the European Patent Office decided to uphold the ruling that royalties are not owed.
.jpg)
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY CATHERINE BRETT
US-based Biogen can celebrate another victory in its drawn-out legal battle against Forward Pharma.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Astrazeneca and EU settle missing vaccines case
For subscribers
